Days
Hours
Minutes
Seconds
Register to the Endotoxin & TOC 2022 conference seminar

Epoch Microplate Reader

Brand:Agilent – Cell Analysis

About the Product

The Agilent Epoch Microplate Spectrophotometer is a highly robust and reliable system that employs monochromator-based optics, negating the need for filters and offering a wide wavelength range for UV-Vis absorbance measurements. Designed to accommodate various microplate formats, the Epoch also supports 2 µL samples via the optional Take3 microvolume plate. Gen5 software interface ensures streamlined programming and sophisticated data analysis. This cost-effective microplate absorbance reader delivers optimal performance, minimizes maintenance requirements, and contributes to significant time savings in laboratory workflows.

 

Key Advantages

  • Filter-free, high-quality optics, and robust hardware provide superior performance and value. 
  • 200 to 999 nm wavelengths for UV-Vis applications expedite nucleic acid and protein quantification in microplates.
  • Microvolume detection: The optional Take3 plate enhances Epoch’s capabilities to small, 2 µL sample volumes for direct DNA, RNA, and protein quantification, providing rapid results for up to 48 samples at a time.
  • Flexible measurement modes: Epoch allows for absorbance measurement in 6- to 384-well formats in endpoint, kinetic, and spectral scan reading modes. 
  • Walkaway processing: Epoch enables the automation of reading processes  combining with the BioStack microplate stacker,for 10, 30, or 50 microplates, freeing lab personnel for other tasks.

 

Applications

  • Advanced absorbance reading: endpoint, kinetic and spectral scan reading modes. 
  • ELISA Assays
  • DNA/RNA Quantification
  • Protein Quantification

Interested in this product?

Ancillary products to this product

Our Brands

כנס Endotoxin & TOC

21-22 מרץ 2022

Endotoxin & TOC Conference

21-22 March 2022

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking “Accept All”, you consent to our use of cookies.

Skip to content